聚焦创伤的认知行为疗法治疗精神病共病创伤后应激障碍的多中心随机对照试验:STAR试验方案
该试验为评估者盲、平行组、实用性随机对照试验,比较聚焦创伤的认知行为疗法联合常规治疗与单纯常规治疗,纳入300名精神病共病创伤后应激障碍成人,主要结局为创伤后应激症状严重程度,随访至随机后24个月。
要点
- 精神病患者中创伤后应激障碍患病率约15%,会加重妄想和幻觉等症状。
- 预试验显示聚焦创伤的心理治疗对精神病患者安全有效。
- 本试验为迄今最大规模,评估整合精神病认知行为疗法的聚焦创伤治疗。
核心结论
- 该干预可能通过减少创伤后应激、精神病和情绪问题症状为患者带来显著获益,使临床医生能够自信地在该人群中实施聚焦创伤治疗,并因减少服务使用而相对常规治疗具有成本效益。
研究设计与样本
- 评估者盲、平行组、实用性随机对照试验,比较聚焦创伤的认知行为疗法联合常规治疗与单纯常规治疗。
- 纳入来自五个精神卫生信托机构的300名有痛苦性创伤后应激和精神病症状的成人,每个站点60名,随机分入两组。
主要发现
- 主要结局为创伤后应激障碍症状严重度;次要结局包括创伤后应激障碍诊断丧失百分比和临床显著变化、精神病症状、情绪健康、物质使用、自杀意念、心理康复、社会功能、健康相关生活质量、服务使用及成本效益。
- 评估时间点为随机化前、4个月(治疗中期)、9个月(治疗结束;主要终点)、24个月(治疗结束后15个月)随机化后。
- 在9个月和24个月评估点之间进行四次每3个月一次的电话,收集过去3个月的服务使用情况。
- 通过参与者(N=35)和治疗师(N=5-10)的定性访谈评估治疗可接受性。
- 内部预试验将确保试验招募和结局数据的完整性,以及治疗方案的安全性和依从性。
关键数值与推荐
- 治疗为手册化,由受训治疗师实施,持续9个月。
- 数据分析遵循意向性治疗原则,使用广义线性混合模型,并按CONSORT-SPI声明报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with psychosis have high rates of trauma, with a post-traumatic stress disorder (PTSD) prevalence rate of approximately 15%, which exacerbates psychotic symptoms such as delusions and hallucinations. Pilot studies have shown that trauma-focused (TF) psychological therapies can be safe and effective in such individuals. This trial, the largest to date, will evaluate the clinical effectiveness of a TF therapy integrated with cognitive behaviour therapy for psychosis (TF-CBTp) on post-traumatic stress symptoms in people with psychosis. The secondary aims are to compare groups on cost-effectiveness; ascertain whether TF-CBTp impacts on a range of other meaningful outcomes; determine whether therapy effects endure; and determine acceptability of the therapy in participants and therapists. METHODS: Rater-blind, parallel arm, pragmatic randomised controlled trial comparing TF-CBTp + treatment as usual (TAU) to TAU only. Adults (N = 300) with distressing post-traumatic stress and psychosis symptoms from five mental health Trusts (60 per site) will be randomised to the two groups. Therapy will be manualised, lasting 9 months (m) with trained therapists. We will assess PTSD symptom severity (primary outcome); percentage who show loss of PTSD diagnosis and clinically significant change; psychosis symptoms; emotional well-being; substance use; suicidal ideation; psychological recovery; social functioning; health-related quality of life; service use, a total of four times: before randomisation; 4 m (mid-therapy); 9 m (end of therapy; primary end point); 24 m (15 m after end of therapy) post-randomisation. Four 3-monthly phone calls will be made between 9 m and 24 m assessment points, to collect service use over the previous 3 months. Therapy acceptability will be assessed through qualitative interviews with participants (N = 35) and therapists (N = 5-10). An internal pilot will ensure integrity of trial recruitment and outcome data, as well as therapy protocol safety and adherence. Data will be analysed following intention-to-treat principles using generalised linear mixed models and reported according to Consolidated Standards of Reporting Trials-Social and Psychological Interventions Statement. DISCUSSION: The proposed intervention has the potential to provide significant patient benefit in terms of reductions in distressing symptoms of post-traumatic stress, psychosis, and emotional problems; enable clinicians to implement trauma-focused therapy confidently in this population; and be cost-effective compared to TAU through reduced service use. TRIAL REGISTRATION: ISRCTN93382525 (03/08/20).
引用
- Peters E, Hardy A, Dudley R, et al. Multisite randomised controlled trial of trauma-focused cognitive behaviour therapy for psychosis to reduce post-traumatic stress symptoms in people with co-morbid post-traumatic stress disorder and psychosis, compared to treatment as usual: study protocol for the STAR (Study of Trauma And Recovery) trial. Trials. 2022. PMID: 35606886. doi:10.1186/s13063-022-06215-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。